Related Experiment Video
Updated: Jul 13, 2026

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
Published on: January 24, 2016
Interferon-Induced Transmembrane Protein-3 Rs12252-G Variant Increases COVID-19 Mortality Potential in Egyptian
Sara M Elessawy1, Abeer Shehab1, Dina A Soliman1
1Department of Clinical Pathology, Allergy and Clinical Immunology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
The interferon-induced transmembrane protein-3 (IFITM3) rs12252 G allele variant is linked to increased COVID-19 mortality. This study found no significant association with disease severity or IL-6 levels in Egyptian patients.
Area of Science:
- Genetics and Molecular Biology
- Infectious Diseases
- Immunology
Background:
- Coronavirus disease 2019 (COVID-19) poses a global health threat.
- Interferon-induced transmembrane protein-3 (IFITM3) gene variants may influence susceptibility to severe viral infections.
- The IFITM3 rs12252 single nucleotide polymorphism (SNP) has been implicated in viral disease outcomes.
Purpose of the Study:
- To investigate the association between the IFITM3 rs12252A>G SNP and COVID-19 severity and mortality in an Egyptian cohort.
- To explore the relationship between this SNP, serum interleukin-6 (IL-6) levels, and intensive care unit (ICU) admission in COVID-19 patients.
Main Methods:
- Cross-sectional study involving 100 Egyptian COVID-19 patients.
- Genotyping of the IFITM3 rs12252 SNP using real-time polymerase chain reaction.
- Quantification of serum IL-6 levels via ELISA.
Main Results:
- The IFITM3 rs12252 A allele was predominant (92.5%), with the G allele present in 7.5%.
- No significant association was found between the IFITM3 rs12252 SNP and COVID-19 severity, ICU admission, or IL-6 levels.
- A significant association was observed between the G allele and increased COVID-19 mortality (p=0.024), with a higher frequency in deceased patients (24.2%) compared to cured patients (8.5%).
Conclusions:
- The G allele variant of IFITM3 rs12252 is significantly associated with higher mortality in COVID-19 patients.
- The IFITM3 rs12252 polymorphism was not significantly linked to disease severity, ICU admission, or IL-6 levels in this cohort.
More Related Videos
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Malaria
Inhibitors of Viral Protein Synthesis

